Table 4.
General characteristics and standard echocardiographic parameters in patients with and without cardiovascular events during follow-up
| Events (n=12) | No events (n=14) | p | |
|---|---|---|---|
|
Age, yrs |
60±2 |
63±4 |
ns |
|
SBP, (mmHg) |
128±9 |
124±12 |
ns |
|
DBP, (mmHg) |
76±10 |
73±8 |
ns |
|
Diabetes, n (%) |
2 (16) |
1 (7) |
ns |
|
Dyslipidemia, n (%) |
4 (33) |
6 (50) |
ns |
|
Smoking, n (%) |
1 (8) |
1 (7) |
ns |
|
Scl-70 antibodies, n (%) |
10 (83) |
4 (28) |
0.03 |
|
Serum levels of Scl-70 antibodies, U/ml |
83.9±57.6 |
17.1±41.7 |
0.047 |
|
LV EDV, ml |
85±7 |
82±6 |
ns |
|
LV ESV, ml |
34±3 |
30±4 |
ns |
|
LV EF, % |
62±3 |
65±2 |
ns |
|
LV Mass, (g/m2) |
72.6±4.3 |
68.4±3.9 |
ns |
|
Mitral E peak velocity, (cm/s) |
63.2±8.5 |
59.5±9.4 |
ns |
|
Mitral A peak velocity, (cm/s) |
62.1±6.7 |
67.9±9.2 |
ns |
|
Mitral E/A ratio |
1.0±0.1 |
0.8±0.2 |
ns |
|
Mitral E deceleration time, (ms) |
176.4±12 |
182.7±18 |
ns |
|
RVOT Prox, mm |
30.9±2.9 |
30.1±2.8 |
ns |
|
RVD1, mm |
33.7±2.6 |
32.9±2.4 |
ns |
|
TAPSE, mm |
20.9±3.1 |
21.8±2.8 |
ns |
|
RV FAC, % |
46.3±5.8 |
47.1±5.4 |
ns |
| sPAP, (mmHg) | 38.5±3 | 36.4±7 | ns |
SBP and DBP: systolic and diastolic blood pressure, respectively. LV: left ventricular; EDV and ESV: end-diastolic and end-systolic volumes, respectively; EF: ejection fraction; RVOT prox: right ventricular outflow tract proximal diameter; RVD1: right ventricular inflow diameter at basal level; TAPSE: tricuspid annular plane systolic excursion; FAC: fractional area change; sPAP: systolic pulmonary arterial pressure.